Spectrum Pharma (SPPI) Tops Q2 EPS by 1c

August 3, 2017 5:35 PM EDT

Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $30.5 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings